Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

Economic Calendar And Watch List: BIOS, CBAY, SRNE, TECH

Published 05/31/2016, 10:15 AM
Updated 05/14/2017, 06:45 AM

Morning Notes

US Futures are relatively flat this morning while European stocks trade slightly lower by -.33%. Friday, Fed Chair Janet Yellen spoke about the improving economy and its ability to endure a rate hike in the very near term. Asian stocks closed mostly higher.

Technicals

SPY Technicals Chart

The SPY (NYSE:SPY) continued its push higher in Friday’s session closing out on the highs. Support will lie at the low of Friday’s range at $209.47, followed by the descending macro former resistance at $209.30, and the low of Thursday at $208.97. Resistance will lie at the high of Friday’s range at $210.25, followed by $210.92 and $211.

Small Cap Watch List

*Please refer to the momentum scanners displayed live in the chat room for potential plays at the market open.

**Others On Watch**

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Teva Pharma Industries Ltd (NYSE:TEVA)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Economic Calendar

8:30 Apr personal spending expected +0.7%

8:30 Apr PCE deflator expected +0.3% m/m and +1.1% y/y

9:00 Mar S&P/CaseShiller composite-20 home price index expected +0.7% m/m and +5.06% y/y

9:45 May Chicago PMI expected +0.1 to 50.5

10:00 May U.S. consumer confidence expected +2.1 to 96.3

10:30 May Dallas Fed manufacturing activity expected +5.9 to -8.0

11:00 USDA weekly grain export inspections

4:00 USDA Weekly Crop Progress

Notable Earnings Before Open

MDT: Medtronic (NYSE:MDT) – EPS Est. $1.26, Rev Est. $7.49B

Notable Earnings After Close

WDAY: Workday – EPS Est. $(.02), Rev Est. $338.68M

May 31st Swing Watch List

BioScrip Inc (NASDAQ:BIOS) – This has been on our watch list before, but always fails to go. Still a good setup either way. Long entry is over 2.75, stop 2. 260. Target is 2.90 and then 3.00. Tight ATR here means you have to monitor it!

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cymabay Therapeu (NASDAQ:CBAY) – A big, speculative bull flag here. Long entry is over 2.50, stop 2.35. Room is to 2.80-2.90, short term.

Sorrento Therape (NASDAQ:SRNE) – Testing a big resistance spot on decent relative volume. Long entry is over 6.71, stop 6.50. Room here is to 7.20 and 7.80.

Bio-Techne Corp (NASDAQ:TECH) – Not showing signs of reversal just yet, but has hit my radar. Will wait for better short setup.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.